Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate

Study of tissue engineered bone nodules by Fourier transform infrared spectroscopy

(2010) Halil Murat Aydin et al.   ANALYST

Atypical fractures of the femur and bisphosphonate therapy

(2010) Andrea Giusti et al.   BONE

Mineral maturity and crystallinity index are distinct characteristics of bone mineral

(2010) Delphine Farlay et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

(2010) A. Michael Parfitt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid

(2010) Sonja Gamsjaeger et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Time sequence of secondary mineralization and microhardness in cortical and cancellous bone from ewes

(2009) Yohann Bala et al.   BONE

Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX)

(2009) P Roschger et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Selective Modification of Bone Quality by PTH, Pamidronate, or Raloxifene

(2008) Tara C Brennan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Severely Suppressed Bone Turnover and Atypical Skeletal Fragility

(2008) Maja Visekruna et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

(2008) A. L. Boskey et al.   OSTEOPOROSIS INTERNATIONAL

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL